Neogen Corporation

Healthcare · Medical Devices

13.00$ +1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Neogen Corporation (NEOG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 870 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NEOG
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	15	19	22	24	35	41	46	55	63	72	86	102	119	141	173	184	208	247	283	321	362	402	414	418	468	527	822	924	895	870
Cost of Revenue	5.6	7.2	8.6	9.9	17	20	22	28	32	35	42	49	59	68	85	92	98	125	143	168	190	212	222	222	253	284	416	462	473	462
Gross Profit	9.7	11	14	14	18	21	25	28	31	37	45	53	59	73	88	92	109	123	140	153	172	190	192	196	215	243	406	463	421	409
Research & Development	1.3	1.4	1.6	1.6	1.8	2.3	2.9	2.9	2.7	3.0	3.3	3.6	4.6	6.3	6.8	6.6	7.8	8.3	9.6	9.9	10	11	13	15	16	17	26	22	21	18
Selling, General & Administrative	6.4	7.6	8.5	8.7	12	13	15	17	19	22	28	32	11	13	15	17	20	24	25	29	34	38	41	44	51	83	201	200	218	245
Total Operating Expenses	8.3	9.7	11	11	13	15	18	20	22	26	31	35	39	46	52	59	69	79	87	97	107	120	124	129	141	184	368	385	412	430
Operating Income	1.4	1.6	2.6	2.4	4.3	5.5	6.8	7.5	8.8	11	14	18	20	27	36	34	41	43	53	56	65	70	68	68	74	59	38	77	9.4	-22
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61	83	283	15	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22	23	0.1	0.1	56	73	72	58
Pre-Tax Income	1.9	2.3	2.7	4.3	4.9	6.0	7.3	7.7	8.9	12	14	18	22	27	35	34	41	43	52	56	67	73	73	72	75	60	-22	-14	-1,133	-9.0
Income Tax Expense	0.1	0.1	0.4	1.2	1.7	2.0	2.5	2.6	3.0	4.2	4.8	6.4	7.8	9.8	12	11	14	15	19	19	23	10	13	13	14	12	0.8	-4.9	-41	-1.1
Net Income	1.8	2.2	2.3	3.1	3.2	3.9	4.8	5.1	5.9	7.9	9.1	12	14	18	23	23	27	28	34	37	44	63	60	59	61	48	-23	-9.4	-1,092	-7.9
EBITDA	2.0	2.3	3.5	3.3	5.6	6.6	7.9	8.9	11	14	17	22	26	32	41	40	48	53	64	69	80	87	91	91	96	84	126	183	-938	171

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings